66.56 USD
+1.53 (+2.35%)
At close: Feb 6, 2026
66.56 USD
0 (0%)
After Hours: 2/6/2026, 8:00:02 PM
LIVN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of LIVN get a neutral evaluation. Nothing too spectacular is happening here. LIVN is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
- LIVN had positive earnings in the past year.
- In the past year LIVN had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: LIVN reported negative net income in multiple years.
- LIVN had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -8.48%, LIVN is in the better half of the industry, outperforming 64.52% of the companies in the same industry.
- With a decent Return On Equity value of -18.76%, LIVN is doing good in the industry, outperforming 61.83% of the companies in the same industry.
- LIVN has a Return On Invested Capital of 8.38%. This is amongst the best in the industry. LIVN outperforms 86.02% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for LIVN is significantly below the industry average of 8.80%.
- The 3 year average ROIC (3.45%) for LIVN is below the current ROIC(8.38%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.48% | ||
| ROE | -18.76% | ||
| ROIC | 8.38% |
ROA(3y)-0.17%
ROA(5y)-4.25%
ROE(3y)-0.33%
ROE(5y)-8.59%
ROIC(3y)3.45%
ROIC(5y)N/A
1.3 Margins
- LIVN has a better Operating Margin (15.01%) than 83.33% of its industry peers.
- LIVN's Operating Margin has improved in the last couple of years.
- Looking at the Gross Margin, with a value of 68.50%, LIVN is in the better half of the industry, outperforming 75.27% of the companies in the same industry.
- LIVN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.01% | ||
| PM (TTM) | N/A | ||
| GM | 68.5% |
OM growth 3Y41.74%
OM growth 5Y18.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LIVN is destroying value.
- The number of shares outstanding for LIVN remains at a similar level compared to 1 year ago.
- The number of shares outstanding for LIVN has been increased compared to 5 years ago.
- The debt/assets ratio for LIVN is higher compared to a year ago.
2.2 Solvency
- LIVN has an Altman-Z score of 1.79. This is a bad value and indicates that LIVN is not financially healthy and even has some risk of bankruptcy.
- LIVN's Altman-Z score of 1.79 is in line compared to the rest of the industry. LIVN outperforms 58.60% of its industry peers.
- The Debt to FCF ratio of LIVN is 2.26, which is a good value as it means it would take LIVN, 2.26 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 2.26, LIVN belongs to the top of the industry, outperforming 86.02% of the companies in the same industry.
- A Debt/Equity ratio of 0.30 indicates that LIVN is not too dependend on debt financing.
- The Debt to Equity ratio of LIVN (0.30) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.26 | ||
| Altman-Z | 1.79 |
ROIC/WACC0.96
WACC8.7%
2.3 Liquidity
- LIVN has a Current Ratio of 1.32. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of LIVN (1.32) is worse than 76.88% of its industry peers.
- A Quick Ratio of 1.12 indicates that LIVN should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.12, LIVN is doing worse than 72.04% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.32 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
- LIVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.24%, which is quite good.
- LIVN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.82% yearly.
- The Revenue has grown by 8.63% in the past year. This is quite good.
- The Revenue has been growing slightly by 2.94% on average over the past years.
EPS 1Y (TTM)12.24%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%23.33%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%12.48%
3.2 Future
- LIVN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.20% yearly.
- LIVN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.67% yearly.
EPS Next Y16.86%
EPS Next 2Y11.85%
EPS Next 3Y10.56%
EPS Next 5Y13.2%
Revenue Next Year10.7%
Revenue Next 2Y8.67%
Revenue Next 3Y7.89%
Revenue Next 5Y7.67%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- LIVN is valuated rather expensively with a Price/Earnings ratio of 17.29.
- Based on the Price/Earnings ratio, LIVN is valued cheaper than 87.10% of the companies in the same industry.
- LIVN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.92.
- LIVN is valuated correctly with a Price/Forward Earnings ratio of 15.79.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of LIVN indicates a rather cheap valuation: LIVN is cheaper than 89.25% of the companies listed in the same industry.
- LIVN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.78.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.29 | ||
| Fwd PE | 15.79 |
4.2 Price Multiples
- 84.41% of the companies in the same industry are more expensive than LIVN, based on the Enterprise Value to EBITDA ratio.
- LIVN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. LIVN is cheaper than 91.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.93 | ||
| EV/EBITDA | 13.52 |
4.3 Compensation for Growth
- LIVN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- LIVN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.03
PEG (5Y)9.52
EPS Next 2Y11.85%
EPS Next 3Y10.56%
5. Dividend
5.1 Amount
- LIVN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
66.56
+1.53 (+2.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners105.72%
Inst Owner Change-1.5%
Ins Owners0.28%
Ins Owner Change0.34%
Market Cap3.63B
Revenue(TTM)1.35B
Net Income(TTM)-217.00M
Analysts82.35
Price Target73.19 (9.96%)
Short Float %3.37%
Short Ratio3.14
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.36%
Min EPS beat(2)18.42%
Max EPS beat(2)20.31%
EPS beat(4)3
Avg EPS beat(4)12.75%
Min EPS beat(4)-0.89%
Max EPS beat(4)20.31%
EPS beat(8)7
Avg EPS beat(8)18.55%
EPS beat(12)11
Avg EPS beat(12)18.19%
EPS beat(16)14
Avg EPS beat(16)14.3%
Revenue beat(2)2
Avg Revenue beat(2)3.07%
Min Revenue beat(2)2.12%
Max Revenue beat(2)4.01%
Revenue beat(4)3
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-2.64%
Max Revenue beat(4)4.01%
Revenue beat(8)7
Avg Revenue beat(8)2.79%
Revenue beat(12)11
Avg Revenue beat(12)3.51%
Revenue beat(16)13
Avg Revenue beat(16)2.69%
PT rev (1m)3.14%
PT rev (3m)12.48%
EPS NQ rev (1m)0.65%
EPS NQ rev (3m)-9.85%
EPS NY rev (1m)0.12%
EPS NY rev (3m)2.96%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-0.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.96%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.29 | ||
| Fwd PE | 15.79 | ||
| P/S | 2.69 | ||
| P/FCF | 18.93 | ||
| P/OCF | 14.48 | ||
| P/B | 3.14 | ||
| P/tB | 27.54 | ||
| EV/EBITDA | 13.52 |
EPS(TTM)3.85
EY5.78%
EPS(NY)4.22
Fwd EY6.33%
FCF(TTM)3.52
FCFY5.28%
OCF(TTM)4.6
OCFY6.91%
SpS24.7
BVpS21.2
TBVpS2.42
PEG (NY)1.03
PEG (5Y)9.52
Graham Number42.86
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.48% | ||
| ROE | -18.76% | ||
| ROCE | 11.71% | ||
| ROIC | 8.38% | ||
| ROICexc | 13.38% | ||
| ROICexgc | 250.34% | ||
| OM | 15.01% | ||
| PM (TTM) | N/A | ||
| GM | 68.5% | ||
| FCFM | 14.23% |
ROA(3y)-0.17%
ROA(5y)-4.25%
ROE(3y)-0.33%
ROE(5y)-8.59%
ROIC(3y)3.45%
ROIC(5y)N/A
ROICexc(3y)4.13%
ROICexc(5y)N/A
ROICexgc(3y)10.29%
ROICexgc(5y)N/A
ROCE(3y)4.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y4.41%
ROICexc growth 3Y38.4%
ROICexc growth 5Y24.59%
OM growth 3Y41.74%
OM growth 5Y18.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
F-Score6
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.26 | ||
| Debt/EBITDA | 1.41 | ||
| Cap/Depr | 132.77% | ||
| Cap/Sales | 4.37% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 101.63% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.32 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 1.79 |
F-Score6
WACC8.7%
ROIC/WACC0.96
Cap/Depr(3y)78.92%
Cap/Depr(5y)67.73%
Cap/Sales(3y)3.13%
Cap/Sales(5y)3.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%23.33%
EPS Next Y16.86%
EPS Next 2Y11.85%
EPS Next 3Y10.56%
EPS Next 5Y13.2%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%12.48%
Revenue Next Year10.7%
Revenue Next 2Y8.67%
Revenue Next 3Y7.89%
Revenue Next 5Y7.67%
EBIT growth 1Y51.48%
EBIT growth 3Y51.06%
EBIT growth 5Y22.44%
EBIT Next Year41.25%
EBIT Next 3Y18.09%
EBIT Next 5Y3.36%
FCF growth 1Y2168.7%
FCF growth 3Y20.84%
FCF growth 5YN/A
OCF growth 1Y532.9%
OCF growth 3Y21.3%
OCF growth 5YN/A
LIVANOVA PLC / LIVN FAQ
Can you provide the ChartMill fundamental rating for LIVANOVA PLC?
ChartMill assigns a fundamental rating of 5 / 10 to LIVN.
Can you provide the valuation status for LIVANOVA PLC?
ChartMill assigns a valuation rating of 6 / 10 to LIVANOVA PLC (LIVN). This can be considered as Fairly Valued.
What is the profitability of LIVN stock?
LIVANOVA PLC (LIVN) has a profitability rating of 6 / 10.
What is the financial health of LIVANOVA PLC (LIVN) stock?
The financial health rating of LIVANOVA PLC (LIVN) is 4 / 10.
Can you provide the expected EPS growth for LIVN stock?
The Earnings per Share (EPS) of LIVANOVA PLC (LIVN) is expected to grow by 16.86% in the next year.